{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:46:49Z","timestamp":1780523209202,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Systemic sclerosis (scleroderma; SSc), a rare and heterogeneous connective tissue disease, remains unclear in terms of its underlying causative genes and effective therapeutic approaches. The purpose of the present study was to identify hub genes, diagnostic markers and explore potential small-molecule drugs of SSc.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The cohorts of data used in this study were downloaded from the Gene Expression Complex (GEO) database. Integrated bioinformatic tools were utilized for exploration, including Weighted Gene Co-Expression Network Analysis (WGCNA), least absolute shrinkage and selection operator (LASSO) regression, gene set enrichment analysis (GSEA), Connectivity Map (CMap) analysis, molecular docking, and pharmacokinetic\/toxicity properties exploration.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Seven hub genes (THY1, SULF1, PRSS23, COL5A2, NNMT, SLCO2B1, and TIMP1) were obtained in the merged gene expression profiles of GSE45485 and GSE76885. GSEA results have shown that they are associated with autoimmune diseases, microorganism infections, inflammatory related pathways, immune responses, and fibrosis process. Among them, THY1 and SULF1 were identified as diagnostic markers and validated in skin samples from GSE32413, GSE95065, GSE58095 and GSE125362. Finally, ten small-molecule drugs with potential therapeutic effects were identified, mainly including phosphodiesterase (PDE) inhibitors (BRL-50481, dipyridamole), TGF-\u03b2 receptor inhibitor (SB-525334), and so on.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study provides new sights into a deeper understanding the molecular mechanisms in the pathogenesis of SSc. More importantly, the results may offer promising clues for further experimental studies and novel treatment strategies.<\/jats:p>","DOI":"10.3389\/fgene.2023.1202561","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:29:11Z","timestamp":1689208151000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Hub genes, diagnostic model, and predicted drugs in systemic sclerosis by integrated bioinformatics analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yue-Mei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Zhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2017.03.020","article-title":"Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses","volume":"77","author":"Abrouk","year":"2017","journal-title":"J. Am. Acad. Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: A comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatol. Oxf."},{"key":"B3","first-page":"3","article-title":"One year in review 2019: Systemic sclerosis","volume":"37","author":"Barsotti","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/biof.41","article-title":"Roles and regulation of thy-1, a context-dependent modulator of cell phenotype","volume":"35","author":"Bradley","year":"2009","journal-title":"Biofactors"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1177\/2050640620944140","article-title":"Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats","volume":"8","author":"Brusilovskaya","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/cvr\/cvs355","article-title":"Prss23 is essential for the snail-dependent endothelial-to-mesenchymal transition during valvulogenesis in zebrafish","volume":"97","author":"Chen","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/s0190-9622(85)70213-7","article-title":"Cutaneous tissue repair: Basic biologic considerations. I","volume":"13","author":"Clark","year":"1985","journal-title":"J. Am. Acad. Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/s0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/antiox9090786","article-title":"The phosphodiesterase type 5 inhibitor sildenafil improves DNA stability and redox homeostasis in systemic sclerosis fibroblasts exposed to reactive oxygen species","volume":"9","author":"Di Luigi","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","article-title":"Proteomics reveals nnmt as a master metabolic regulator of cancer-associated fibroblasts","volume":"569","author":"Eckert","year":"2019","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clindermatol.2013.01.010","article-title":"Scleroderma: Nomenclature, etiology, pathogenesis, prognosis, and treatments: Facts and controversies","volume":"31","author":"Fett","year":"2013","journal-title":"Clin. Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1083\/jcb.201505007","article-title":"Conformational coupling of integrin and thy-1 regulates fyn priming and fibroblast mechanotransduction","volume":"211","author":"Fiore","year":"2015","journal-title":"J. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ajpath.2013.02.016","article-title":"The c-rel subunit of nf-\u03bab regulates epidermal homeostasis and promotes skin fibrosis in mice","volume":"182","author":"Fullard","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1124\/jpet.104.082099","article-title":"Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type i receptor kinase in puromycin-induced nephritis","volume":"313","author":"Grygielko","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s10165-012-0795-6","article-title":"Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: A multicenter, prospective, observational study","volume":"23","author":"Hasegawa","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexmp.2006.12.003","article-title":"Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis","volume":"83","author":"Higashiyama","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into tgf-\u03b2\/smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1046\/j.1523-1755.2001.00933.x","article-title":"Dipyridamole inhibits tgf-beta-induced collagen gene expression in human peritoneal mesothelial cells","volume":"60","author":"Hung","year":"","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1046\/j.1523-1755.2001.060003872.x","article-title":"Dipyridamole inhibits pdgf-stimulated human peritoneal mesothelial cell proliferation","volume":"60","author":"Hung","year":"","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1046\/j.1523-1755.2001.00749.x","article-title":"Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo","volume":"59","author":"Hung","year":"","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part i: Clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.3390\/ijms23073769","article-title":"Context dependent sulf1\/sulf2 functional divergence in endothelial cell activity","volume":"23","author":"Justo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.45.9.718","article-title":"Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma","volume":"45","author":"Kahan","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/acr.21799","article-title":"Soluble cd90 as a potential marker of pulmonary involvement in systemic sclerosis","volume":"65","author":"Kollert","year":"2013","journal-title":"Arthritis Care Res. Hob."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1172\/jci88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"Wgcna: An r package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinforma."},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2021.07.002","article-title":"Pm2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing tgf-\u03b21","volume":"569","author":"Leilei","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1136\/annrheumdis-2016-210189","article-title":"Inhibition of phosphodiesterase 4 (pde4) reduces dermal fibrosis by interfering with the release of interleukin-6 from m2 macrophages","volume":"76","author":"Maier","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e149426","DOI":"10.1172\/jci.insight.149426","article-title":"Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma","volume":"7","author":"Marangoni","year":"2022","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12016-022-08951-z","article-title":"A summary on the genetics of systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and sj\u00f6gren's syndrome","volume":"64","author":"Ort\u00edz-Fern\u00e1ndez","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1096\/fj.05-5460rev","article-title":"Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis","volume":"20","author":"Rege","year":"2006","journal-title":"Faseb J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa2201737","article-title":"Trial of a preferential phosphodiesterase 4b inhibitor for idiopathic pulmonary fibrosis","volume":"386","author":"Richeldi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/19768354.2021.1995486","article-title":"Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis","volume":"25","author":"Roh","year":"2021","journal-title":"Anim. Cells Syst. Seoul."},{"key":"B36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biocel.2016.09.021","article-title":"Tumour-necrosis factor-\u03b1 induces heparan sulfate 6-o-endosulfatase 1 (sulf-1) expression in fibroblasts","volume":"80","author":"Sikora","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/rheumatology\/39.12.1332","article-title":"Association of markers for tgfbeta3, tgfbeta2 and timp1 with systemic sclerosis","volume":"39","author":"Susol","year":"2000","journal-title":"Rheumatol. Oxf."},{"key":"B38","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The gene ontology resource: 20 years and still going strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","article-title":"Activin-like kinase 5 (alk5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline","volume":"174","author":"Thomas","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the eular scleroderma trials and research (eustar) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1093\/rheumatology\/keaa272","article-title":"Crel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis","volume":"59","author":"Worrell","year":"2020","journal-title":"Rheumatol. Oxf."},{"key":"B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.55563\/clinexprheumatol\/b9j9fd","article-title":"Insulin-like growth factor binding protein 7 as a candidate biomarker for systemic sclerosis","volume":"39","author":"Yan","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1202561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:29:15Z","timestamp":1689208155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1202561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":43,"alternative-id":["10.3389\/fgene.2023.1202561"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1202561","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"article-number":"1202561"}}